Literature DB >> 28734893

Genetic polymorphisms in CYP2A6 are associated with a risk of cigarette smoking and predispose to smoking at younger ages.

Gloria Pérez-Rubio1, Luis Alberto López-Flores1, Alejandra Ramírez-Venegas2, Valeri Noé-Díaz2, Leonor García-Gómez2, Enrique Ambrocio-Ortiz1, Candelaria Sánchez-Romero2, Rafael De Jesús Hernández-Zenteno2, Raúl Humberto Sansores3, Ramcés Falfán-Valencia4.   

Abstract

Nicotine is the main component of cigarettes that causes addiction, which is considered a complex disease, and genetic factors have been proposed to be involved in the development of addiction. The CYP2A6 gene encodes the main enzyme responsible for nicotine metabolism. Depending on the study population, different genetic variants of CYP2A6 associated with cigarette smoking have been described. Therefore, we evaluated the possible association between SNPs in CYP2A6 with cigarette smoking and nicotine addiction-related variables in Mexican mestizo smokers. We performed a genetic association study comparing light smokers (LS, n=349), heavy smokers (HS, n=351) and never-smokers (NS, n=394). SNPs rs1137115, rs4105144, rs1801272 and rs28399433 were genotyped in the CYP2A6 gene. We found that the A allele of rs1137115 (OR=1.41) in exon 1 of CYP2A6 and the T allele of rs4105144 (OR=1.32) in the 5' UTR of the gene are associated with the risk of cigarette smoking (p<0.05); rs1137115 affects the level of alternative splicing, resulting in a CYP2A6 isoform with low enzymatic activity, whereas rs4105144 is likely to be in a binding site for the transcription factor for glucocorticoids receptor (GR) and regulates the expression of CYP2A6. In addition, having a greater number of risk alleles (rs1137115 (A), rs4105144 (T) and rs28399433 (G)) is associated with a younger age at onset. The present study shows that in Mexican mestizos, the analyzed SNPs confer greater risk in terms of consumption and age of onset.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  CYP2A6; Genetics of addiction; Mexican mestizo; Nicotine addiction; Nicotine metabolism

Mesh:

Substances:

Year:  2017        PMID: 28734893     DOI: 10.1016/j.gene.2017.07.051

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  15 in total

1.  Nitric Oxide Mediated Degradation of CYP2A6 via the Ubiquitin-Proteasome Pathway in Human Hepatoma Cells.

Authors:  John Cerrone; Choon-Myung Lee; Tian Mi; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2020-04-29       Impact factor: 3.922

2.  Impact of early life adversity on the stress biobehavioral response during nicotine withdrawal.

Authors:  Mustafa al'Absi; Motohiro Nakajima; Andrine Lemieux
Journal:  Psychoneuroendocrinology       Date:  2018-08-15       Impact factor: 4.905

3.  Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline.

Authors:  Paulo Roberto Xavier Tomaz; Mariana Soares Kajita; Juliana Rocha Santos; Jaqueline Scholz; Tânia Ogawa Abe; Patrícia Viviane Gaya; José Eduardo Krieger; Alexandre Costa Pereira; Paulo Caleb Júnior Lima Santos
Journal:  Eur J Clin Pharmacol       Date:  2019-08-11       Impact factor: 2.953

4.  Genetic variations in the bitter taste receptor gene TAS2R38 are related to cigarette smoking behavior in Han Chinese smokers.

Authors:  Fei-Yan Qi; Zhou-Hai Zhu; Meng Li; Ying Guan; Qi-Yuan Peng; She-Ming Lu; Zhi-Hua Liu; Ming-Feng Wang; Ming-Ming Miao; Zhang-Yu Chen; Xue-Mei Li; Jie Bai; Jian-Hua Yao; Jianhua Yao
Journal:  Genes Genomics       Date:  2022-09-20       Impact factor: 2.164

Review 5.  Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism.

Authors:  Yadira X Perez-Paramo; Philip Lazarus
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-12-29       Impact factor: 4.481

Review 6.  The Effects of Nicotine on Development.

Authors:  Sharon A McGrath-Morrow; Julie Gorzkowski; Judith A Groner; Ana M Rule; Karen Wilson; Susanne E Tanski; Joseph M Collaco; Jonathan D Klein
Journal:  Pediatrics       Date:  2020-02-11       Impact factor: 9.703

7.  Data on polymorphisms in CYP2A6 associated to risk and predispose to smoking related variables.

Authors:  Luis A López-Flores; Gloria Pérez-Rubio; Alejandra Ramírez-Venegas; Enrique Ambrocio-Ortiz; Raúl H Sansores; Ramcés Falfán-Valencia
Journal:  Data Brief       Date:  2017-09-13

Review 8.  Genomic and Bioinformatics Approaches for Analysis of Genes Associated With Cancer Risks Following Exposure to Tobacco Smoking.

Authors:  Mohammed A I Al-Obaide; Buthainah A Ibrahim; Saif Al-Humaish; Abdel-Salam G Abdel-Salam
Journal:  Front Public Health       Date:  2018-03-20

9.  Genetic variants in CYP2A6 and UGT1A9 genes associated with urinary nicotine metabolites in young Mexican smokers.

Authors:  Gissela Borrego-Soto; Yadira X Perez-Paramo; Gang Chen; Sandra K Santuario-Facio; Jesus Santos-Guzman; Rodolfo Posadas-Valay; Fatima M Alvarado-Monroy; Isaias Balderas-Renteria; Ramses Medina-Gonzalez; Rocio Ortiz-Lopez; Philip Lazarus; Augusto Rojas-Martinez
Journal:  Pharmacogenomics J       Date:  2020-01-21       Impact factor: 3.550

10.  A Machine Learning-Based Identification of Genes Affecting the Pharmacokinetics of Tacrolimus Using the DMETTM Plus Platform.

Authors:  Jeong-An Gim; Yonghan Kwon; Hyun A Lee; Kyeong-Ryoon Lee; Soohyun Kim; Yoonjung Choi; Yu Kyong Kim; Howard Lee
Journal:  Int J Mol Sci       Date:  2020-04-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.